+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Digital Dose Inhaler Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5483456
  • Report
  • November 2021
  • Region: Global
  • 143 Pages
  • IMARC Group

FEATURED COMPANIES

  • 3M Company
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Lupin Limited
  • Novartis AG
The global digital dose inhaler market exhibited strong growth during 2015-2020. Looking forward, the publisher expects the market to grow at a CAGR of around 12% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Digital dose inhalers are utilized to provide a simple, accurate, and reliable dose counter, which enables asthma and chronic obstructive pulmonary disease (COPD) patients to track adherence to their therapy. These inhalers comprise sensors that record the time of medication administration and provide a low-dose warning indicator. They also offer a large display for easy accessibility and comprehension by varied patient populations. Nowadays, digital dose inhalers are integrated with Bluetooth technology that assists in pairing with a tablet, smartphone, or computer wirelessly to enable the automatic transfer of data.

Digital Dose Inhaler Market Trends:

A considerable rise in the number of individuals diagnosed with chronic respiratory diseases (CRDs), such as bronchial asthma, lung disorders, pulmonary hypertension (PH) and chronic obstructive pulmonary disease (COPD), represents one of the key factors driving the demand for digital dose inhalers worldwide. Additionally, the risk of developing CRDs is increasing around the world on account of the growing number of tobacco smokers, rising levels of air pollution, and occupational dust exposure in the agriculture, forestry, and mining settings. This, in turn, is bolstering the market growth. Apart from this, governing agencies of numerous countries, along with non-governmental organizations (NGOs), are introducing several programs to spread awareness about CRDs and the available treatments. Moreover, dry powder inhaler (DPI) systems are gaining traction as they target the delivery of fine drug particles to the deeper airways in the lungs. As a result, several manufacturers are offering capsule-based and disposable DPI devices with improved reliability, consistency, and cost-effectiveness, which is driving the market. Furthermore, favorable reimbursement policies available to the patients via government-sponsored plans and individual insurance and employee policies are boosting the treatment rates of respiratory disorders. This, in turn, is projected to stimulate the growth of the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global digital dose inhaler market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type and product.

Breakup by Type:

  • Branded Medication
  • Generics Medication

Breakup by Product:

  • Metered Dose Inhaler
  • Dry Powder Inhaler

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AstraZeneca plc, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, H&T Presspart Manufacturing Ltd., Koninklijke Philips N.V., Lupin Limited, Novartis AG, OPKO Health Inc., Propeller Health (ResMed), Sensirion AG Switzerland and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

  • How has the global digital dose inhaler market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global digital dose inhaler market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the product?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global digital dose inhaler market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Lupin Limited
  • Novartis AG
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Digital Dose Inhaler Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type
6.1 Branded Medication
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Generics Medication
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Product
7.1 Metered Dose Inhaler
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Dry Powder Inhaler
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast

9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 3M Company
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 AstraZeneca plc
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 GlaxoSmithKline plc
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.4 Glenmark Pharmaceuticals Limited
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 H&T Presspart Manufacturing Ltd.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Koninklijke Philips N.V.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Lupin Limited
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Novartis AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 OPKO Health Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.10 Propeller Health (ResMed)
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11 Sensirion AG Switzerland
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.12 Teva Pharmaceutical Industries Ltd.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials

List of Figures
Figure 1: Global: Digital Dose Inhaler Market: Major Drivers and Challenges
Figure 2: Global: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Digital Dose Inhaler Market: Breakup by Type (in %), 2020
Figure 5: Global: Digital Dose Inhaler Market: Breakup by Product (in %), 2020
Figure 6: Global: Digital Dose Inhaler Market: Breakup by Region (in %), 2020
Figure 7: Global: Digital Dose Inhaler (Branded Medication) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Digital Dose Inhaler (Branded Medication) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Digital Dose Inhaler (Generics Medication) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Digital Dose Inhaler (Generics Medication) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Digital Dose Inhaler (Metered Dose Inhaler) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Digital Dose Inhaler (Metered Dose Inhaler) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Digital Dose Inhaler (Dry Powder Inhaler) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Digital Dose Inhaler (Dry Powder Inhaler) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: North America: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: North America: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: United States: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: United States: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Canada: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Canada: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Asia-Pacific: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Asia-Pacific: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: China: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: China: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Japan: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Japan: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: India: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: India: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: South Korea: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: South Korea: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Australia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Australia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Indonesia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Indonesia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Europe: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Europe: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Germany: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Germany: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: France: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: France: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: United Kingdom: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: United Kingdom: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Italy: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Italy: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Spain: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Spain: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Russia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Russia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Latin America: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Latin America: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Brazil: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Brazil: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Mexico: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Mexico: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Middle East and Africa: Digital Dose Inhaler Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Middle East and Africa: Digital Dose Inhaler Market: Breakup by Country (in %), 2020
Figure 63: Middle East and Africa: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Global: Digital Dose Inhaler Industry: SWOT Analysis
Figure 65: Global: Digital Dose Inhaler Industry: Value Chain Analysis
Figure 66: Global: Digital Dose Inhaler Industry: Porter's Five Forces Analysis

List of Tables
Table 1: Global: Digital Dose Inhaler Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Digital Dose Inhaler Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Digital Dose Inhaler Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 4: Global: Digital Dose Inhaler Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Digital Dose Inhaler Market: Competitive Structure
Table 6: Global: Digital Dose Inhaler Market: Key Players
Note: Product cover images may vary from those shown
  • 3M Company
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Limited
  • H&T Presspart Manufacturing Ltd.
  • Koninklijke Philips N.V.
  • Lupin Limited
  • Novartis AG
  • OPKO Health Inc.
  • Propeller Health (ResMed)
  • Sensirion AG Switzerland
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...